BioCentury
ARTICLE | Company News

AquaMed Technologies Inc., HepaLife Technologies deal

July 26, 2010 7:00 AM UTC

HepaLife completed its previously announced acquisition of drug delivery company AquaMed in a stock deal. AquaMed stockholders received 84.8 million HepaLife shares, which values AquaMed at $9.3 milli...